{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/001/SRR23423401/SRR23423401_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/003/SRR23423403/SRR23423403_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/005/SRR23423405/SRR23423405_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/007/SRR23423407/SRR23423407_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/003/SRR23423403/SRR23423403_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/004/SRR23423404/SRR23423404_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/001/SRR23423401/SRR23423401_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/006/SRR23423406/SRR23423406_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/002/SRR23423402/SRR23423402_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/006/SRR23423406/SRR23423406_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/002/SRR23423402/SRR23423402_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/005/SRR23423405/SRR23423405_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/004/SRR23423404/SRR23423404_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR234/007/SRR23423407/SRR23423407_1.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Anhui medical university"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA932946"],"long_description":["Our studies demonstrate the potential of using macrophages as a platform for CAR technology to provide an effective treatment option for liver fibrosis."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"","description":"CAR modified macrophages ameliorate liver fibrosis in preclinical models","dates":{"last_updated":"2024-01-02","first_public":"2024-01-02"},"accession":"PRJNA932946","cross_references":{}}